'California Senator Plans To File Therapeutic Psychedelics Bill With Republican Support Following Governor's Veto Of Broader Legalization' - Marijuana Moment
Portfolio Pulse from Benzinga Newsdesk
California Senator Scott Wiener plans to introduce a revised bill next year to provide regulated therapeutic access to psychedelics, following Governor Gavin Newsom's veto of a broader legalization measure. The new bill, co-sponsored with Assemblymember Marie Waldron, will be crafted in response to Newsom's veto message, which called for regulated treatment guidelines before decriminalization. The bill will focus on providing access to regulated psychedelic therapies administered by licensed and vetted facilitators.
November 07, 2023 | 3:22 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
The revised bill in California could potentially impact the operations of Compass Pathways, a company involved in psychedelic therapies.
If the bill passes, it could potentially increase the demand for Compass Pathways' psychedelic therapies in California.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
The revised bill in California could potentially impact the operations of Cybin, a company involved in psychedelic therapies.
If the bill passes, it could potentially increase the demand for Cybin's psychedelic therapies in California.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
The revised bill in California could potentially impact the operations of the AdvisorShares Pure US Cannabis ETF, which includes companies involved in psychedelic therapies.
If the bill passes, it could potentially increase the demand for the psychedelic therapies provided by companies included in the AdvisorShares Pure US Cannabis ETF.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
The revised bill in California could potentially impact the operations of Enveric Biosciences, a company involved in psychedelic therapies.
If the bill passes, it could potentially increase the demand for Enveric Biosciences' psychedelic therapies in California.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
The revised bill in California could potentially impact the operations of MindMed, a company involved in psychedelic therapies.
If the bill passes, it could potentially increase the demand for MindMed's psychedelic therapies in California.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
The revised bill in California could potentially impact the operations of Seelos Therapeutics, a company involved in psychedelic therapies.
If the bill passes, it could potentially increase the demand for Seelos Therapeutics' psychedelic therapies in California.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
The revised bill in California could potentially impact the operations of companies included in the SPDR S&P 500 ETF, which may include companies involved in psychedelic therapies.
If the bill passes, it could potentially increase the demand for the psychedelic therapies provided by companies included in the SPDR S&P 500 ETF.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70